SpyBiotech

📍 Oxford, United Kingdom🗓 Founded 2017👥 16 employees💰 Last funded Oct 2021
Biotechnology Research🌐 spybiotech.com
Website LinkedIn
SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in SpyBiotech?
SpyBiotech has 1 investors on record on gritt.io, 1 mid-stage.
When did SpyBiotech last raise funding?
The most recent investment in SpyBiotech recorded on gritt.io was in October 2021.
When was SpyBiotech founded?
SpyBiotech was founded in 2017.
What industry is SpyBiotech in?
SpyBiotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SpyBiotech based?
SpyBiotech is headquartered in Oxford, United Kingdom.